
UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Group approach may increase accessibility to psychedelic therapy
In a bid to increase accessibility, a new study by the Australian National University (ANU) School of Medicine and Psychology will look into the viability of the application of psychedelics in a group setting. The study will focus on the psychological, cognitive and physical effects, including adverse events, of taking psilocybin and MDMA in a group setting.
Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder
Findings of the study showed safety (no treatment-related serious adverse events or suicidality) with psilocybin and suggested efficacy, with a significant reduction in depression severity scores from baseline to posttreatment. Further investigation is warranted.
Group psychedelic therapy: empirical estimates of cost-savings and improved access
Adopting group therapy protocols where feasible would significantly reduce the cost of psychedelic-assisted therapies.
HOPE: A pilot study of psilocybin enhanced group psychotherapy in patients with cancer
This pilot study demonstrated the safety, feasibility, and possible efficacy of psilocybin-assisted group therapy for cancer patients dealing with depressive symptoms. Based on demonstrated efficacy and significant reductions in therapist time, future investigations with the group therapy model are warranted.
In naturalistic psychedelic use, group use is common and acceptable
Naturalistic psychedelic users are as likely to report an overall positive outcome and no more likely to report adverse events in group settings than in solo settings. This supports further research into PAP in group settings.
Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial
Suggestions are provided for protocol design, screening processes, space considerations, therapist team structure, group process, music, timeline, as well as potential issues and challenges.
Group therapy holds promise for psychedelic-based treatments
“Those meetings are beautiful,” he says. “They’ve given me a real appreciation of how empowering it is for a cancer patient to help other cancer patients.”
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
We hope for this article to support clinical research on PAGP by presenting a therapeutic framework and outlining its mechanisms and challenges.
Sober sitter or coconsumer? Psychedelics, online forums and preferences for interpersonal interactions
There was disparity between consumer preferences and guidelines ... concerning consumer agency; consumption alongside others, and carers who had consumed psychedelics themselves.
Using a MDMA- and LSD-group therapy model in clinical practice in Switzerland and highlighting the treatment of trauma-related disorders
The majority of the patients taking part in the psychedelic group therapy suffered from chronic complex post-traumatic stress disorder